HemaXis Overview

  • Founded

  • 2010

Founded
  • Status

  • Private

  • Employees

  • 6

Employees
  • Latest Deal Type

  • Grant

  • Latest Deal Amount

  • $56.3K

  • Investors

  • 4

HemaXis General Information

Description

Developer of a blood collection device designed to revolutionize the potential of micro blood samples at the fingertip. The company's device can be used for blood collection with the ability to do standardized blood sampling and analysis at any time and by anyone, enabling medical labs to test and monitor blood easily.

Contact Information

Website
www.hemaxis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Primary Office
  • Route des Avouillons 6
  • 1196 Gland
  • Switzerland
+41 078 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HemaXis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 26-Jul-2019 $56.3K 00.000 Completed Generating Revenue
3. Later Stage VC (Series A) 03-May-2017 00.00 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 09-Jul-2015 $641K $641K Completed Generating Revenue
1. Grant 01-Jan-2012 $128K Completed Startup
To view HemaXis’s complete valuation and funding history, request access »

HemaXis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a blood collection device designed to revolutionize the potential of micro blood samples at the fingertip.
Other Devices and Supplies
Gland, Switzerland
6 As of 2022
00.000
0000000000 00.000

00000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
0000000000 000000000
Seattle, WA
00 As of 0000
00000
000000 - 000 00000

000000

em ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inci
00000 0000000 000 00
Medford, MA
00 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HemaXis Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tasso Venture Capital-Backed Seattle, WA 00 00000 000000 - 000 00000
0000000 Venture Capital-Backed Medford, MA 00 000.00 0000000000 0 000.00
000000 Formerly VC-backed Union City, CA 000 000.00 000000&0 000.00
00000 000000 Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
0000 00 00000000 Private Equity-Backed San Francisco, CA 00 000000000000
You’re viewing 5 of 8 competitors. Get the full list »

HemaXis Patents

  • 14

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

HemaXis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3335794-A1 Device and method for detecting the deposition of a biological liquid sample on a substrate Inactive 13-Dec-2016 000000000000 0
US-20180164281-A1 Device and method for detecting the deposition of a biological liquid sample on a substrate Inactive 13-Dec-2016 000000000000 0
AU-2015232998-A1 Device and method for separating a fluid mixture such as blood Inactive 21-Mar-2014 0000000000
EP-3119519-A1 Device and method for separating a fluid mixture such as blood Active 21-Mar-2014 0000000000
EP-3119519-B1 Device and method for separating blood Active 21-Mar-2014 G01N33/491
To view HemaXis’s complete patent history, request access »

HemaXis Executive Team (7)

Name Title Board Seat Contact Info
Eric Ödman Co-Founder & Chief Executive Officer
Julien Déglon Ph.D Co-Founder & Chief Technology Officer
Aurelien Thomas Ph.D Co-Founder
You’re viewing 3 of 7 executive team members. Get the full list »

HemaXis Board Members (1)

Name Representing Role Since
Louis Frachon Self Board Member 000 0000
To view HemaXis’s complete board members history, request access »

HemaXis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HemaXis Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
Nest Sammelstiftung Limited Partner Minority 000 0000 000000 0
Verve Ventures Angel Group Minority 000 0000 000000 0
Swiss Federal Commission for Innovation and Technology Government 000 0000 000000 0
To view HemaXis’s complete investors history, request access »

Ready to get started?

Request a free trial